+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
From
Cancer Immunotherapy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cancer Immunotherapy Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
Transplantation Market Report and Forecast 2023-2031 - Product Thumbnail Image

Transplantation Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Antihypertensives: Global Markets to 2023 - Product Thumbnail Image

Antihypertensives: Global Markets to 2023

  • Report
  • January 2019
  • 144 Pages
  • Global
From
Cardiovascular Drugs: Global Markets to 2022 - Product Thumbnail Image

Cardiovascular Drugs: Global Markets to 2022

  • Report
  • March 2018
  • 174 Pages
  • Global
From
In Vitro ADME Testing Services Market, 2019-2030 - Product Thumbnail Image

In Vitro ADME Testing Services Market, 2019-2030

  • Report
  • January 2019
  • 317 Pages
  • Global
From
Fibroblast Growth Factor Receptor 4 (FGFR4) Antagonist - Product Thumbnail Image

Fibroblast Growth Factor Receptor 4 (FGFR4) Antagonist

  • Clinical Trials
  • June 2022
  • 65 Pages
  • Global
From
Analyzing the Global Pharmaceutical Industry 2022 - Product Thumbnail Image

Analyzing the Global Pharmaceutical Industry 2022

  • Report
  • November 2022
  • 500 Pages
  • Global
From
From
Loading Indicator